UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )
|
Filed by the Registrant x | |||
|
| |||
|
Filed by a Party other than the Registrant o | |||
|
| |||
|
Check the appropriate box: | |||
|
o |
Preliminary Proxy Statement | ||
|
o |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | ||
|
o |
Definitive Proxy Statement | ||
|
x |
Definitive Additional Materials | ||
|
o |
Soliciting Material under §240.14a-12 | ||
|
| |||
|
JAGUAR HEALTH, INC. | |||
|
(Name of Registrant as Specified In Its Charter) | |||
|
| |||
|
| |||
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant) | |||
|
| |||
|
Payment of Filing Fee (Check the appropriate box): | |||
|
x |
No fee required. | ||
|
o |
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | ||
|
|
(1) |
Title of each class of securities to which transaction applies: | |
|
|
|
| |
|
|
(2) |
Aggregate number of securities to which transaction applies: | |
|
|
|
| |
|
|
(3) |
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): | |
|
|
|
| |
|
|
(4) |
Proposed maximum aggregate value of transaction: | |
|
|
|
| |
|
|
(5) |
Total fee paid: | |
|
|
|
| |
|
o |
Fee paid previously with preliminary materials. | ||
|
o |
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | ||
|
|
(1) |
Amount Previously Paid: | |
|
|
|
| |
|
|
(2) |
Form, Schedule or Registration Statement No.: | |
|
|
|
| |
|
|
(3) |
Filing Party: | |
|
|
|
| |
|
|
(4) |
Date Filed: | |
|
|
|
| |
Jaguar Health, Inc. recorded a call script that encourages stockholders to vote on the proposals outlined in the proxy materials. Included herein is a transcript of the recording.
Hello, this is Lisa Conte, founder and CEO of Jaguar Health. Our records show that you are or were a stockholder of Jaguar as of the record date for our annual shareholder meeting obligation. I would be so grateful if you would vote your proxy which you are entitled to do even if you sold your shares and no longer own them. Jaguar’s annual meeting was adjourned as we did not have sufficient shares to achieve quorum. We are very, very, very close to quorum, so no matter how many or how few shares you own, your vote is extremely important for Jaguar to meet its obligations and shareholders to have their voice heard. The adjourned meeting will be held on September 3rd. However, you can vote today. So it doesn’t matter if you vote “for”, or “against” or “abstain” — what’s important is that your shares are represented at the meeting so we get to quorum. You can contact our proxy solicitor, toll free, at 1-866-821-0284 from 9 in the morning to 11 p.m. Eastern time and from noon to 6 p.m. even on Saturdays. Again, 866-821-0284. Their name is Georgeson, and they can assist you with voting over the telephone today — today please. And this will assist our shareholders and our company obligations. You also can reach out to me directly — this is how important is it, the CEO — [XXXXXXX]. Thank you in advance for your attention, listening to this message, and helping us achieve quorum for our shareholder meeting and for the shareholders. Thank you, bye bye.